763 results on '"Cheong, June-Won"'
Search Results
2. Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes
3. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
4. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources
5. Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis
6. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
7. Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
8. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
9. The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
10. Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients
11. Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest
12. Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights
13. Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation
14. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
15. NUP98is rearranged in 5.0% of adult East Asian patients with AML
16. Immunoglobulin Gene Clonality Analysis using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients
17. Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3
18. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma.
19. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma
20. Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
21. Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease
22. NUP98 is rearranged in 5.0% of adult East Asian patients with AML
23. Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/−DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia
24. A population pharmacokinetic model of methotrexate in Korean patients with hematologic malignancy
25. Different prognostic effects of core-binding factor positive AML with Korean AML registry data
26. Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors
27. P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL.
28. P1042: COMPARISON OF THE RESPONSE TO ROPEGINTERFERON ALFA-2B IN HYDROXYUREA NAÏVE VERSUS RESISTANCE/INTOLERANCE POLYCYTHEMIA VERA: THE KOREAN SINGLE-ARM, OPEN-LABEL MULTICENTER STUDY
29. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of “RISK” Study
30. Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study
31. Prognostic significance of interventricular septal thickness in patients with AL amyloidosis
32. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
33. ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
34. PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells
35. An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation
36. Changing the strategic paradigm for the treatment of adult acute myeloid leukemia
37. Supplementary Figures S1-S5 and Legends from AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
38. Supplementary Data from Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
39. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease
40. Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
41. DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
42. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
43. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma
44. The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma
45. Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience
46. A Potent Small Molecule Inhibitor of FLT3, PHI-101 Overcomes Resistance in Acute Myeloid Leukemia: Efficacy and PK/PD Profile in Phase 1 First in Human Study
47. A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit
48. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression
49. High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma
50. Utility of Plasma Microbial Cell-Free DNA Whole-Genome Sequencing for Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancy or COVID-19.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.